Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
hepatitis b
4
×
life sciences
national blog main
national top stories
boston
clinical trials
deals
san francisco blog main
alexion pharmaceuticals
alnylam pharmaceuticals
boehringer ingelheim
fda
rna interference
san francisco top stories
aligos therapeutics
alnylam pharmaceutials
arrowhead pharmaceuticals
baker brothers life sciences
beijing
benzodiazepine
biotech ipos
blackstone group
blepharitis
brii bio
brii biosciences
cavion
cephalgia
china
chronic hepatitis b virus
david goldstein
demodex blepharitis
depression
dicerna pharamceuticals
dicerna pharmaceuticals
eli lilly
epilepsy
essential tremor
What
medicines
4
×
dicerna
disease
drug
hepatitis
pharma
research
abandoning
adds
ago
alliance
areas
baggage
biosciences
biotechs
bio’s
brii
caught
causing
central
cns
companies
cuts
deal
development
disorder
drugs
earlier
emerged
eye
free
gene
gets
infectious
intended
interference
ipos
kept
launched
leads
Language
unset
Current search:
biotech
×
medicines
×
" hepatitis b "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
